McBride plc (MCB)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 175.00 |
|---|---|
| 52-week range | 107.60 – 214.10 |
| Return, 1 month / 3 months | +0.0% / +10.2% |
| Return, 1 year / 3 years | +45.3% / +347.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 41.5% |
| Worst drawdown (1 year) | -19.2% |
| Average daily value traded | 50.71M GBX |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
McBride plc is a British manufacturer of household and personal care products made for retailers' own brands. It produces laundry detergents, cleaning sprays and liquids, dishwasher products and personal care items such as shampoos and shower gels. Its customers are mainly supermarkets and other retailers in the UK and continental Europe who sell these goods under their own labels. The company is based in the United Kingdom and also makes products for the professional and industrial cleaning market.
McBride plc trades under the code MCB on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
McBride plc (MCB) trades on the London Stock Exchange in UK. It last closed at GBX 175.00 on 27 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 884 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 45.3% and over the last three months it rose 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.4% | ||
| From 52-week high | -15.0% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.2% | ||
| 6-month return | 10.6% | ||
| 12-month return, skipping the last month | 45.3% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.2% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 50.71M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 15 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | +0.0% |
| 3 months | +10.2% |
| 6 months | +10.6% |
| 1 year | +45.3% |
| 3 years | +347.8% |
| 5 years | +154.3% |
Signals
| 50-day / 200-day average | 179.83 / 161.47 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Oct 2026 | GBP 0.0310 |
| 30 Oct 2025 | GBP 0.0300 |
| 22 Oct 2020 | GBP 0.0110 |
| 24 Oct 2019 | GBP 0.0180 |
| 31 May 2019 | GBP 0.0150 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.